We posted a couple of weeks ago about Professor Adam Pritchard’s proposal to amend corporate articles of incorporation to waive the fraud-on-the-market presumption of reliance in securities fraud cases. That would basically eliminate securities class action lawsuits against companies that adopted the amendment (prospectively — from the date the amendment was adopted).

Securities Docket has now picked up on this idea, publishing an interview with Professor Pritchard and Pritchard’s “Model Rule 14a-8 Proposal” to be submitted by a shareholder.

We know, we know: This isn’t drugs and devices.

But it could potentially affect drug companies (along with all other public companies). And besides, we do a lot of stuff other than drug and device law. We just don’t have time to publish posts about our other interests.